Your service entry point
for custom microfluidic assays
Services

Screening & Fluidics provides Ultra-High Throughput Screening Services using its GotaHit Fluorescence Activated Droplet Sorting (FADS) platform in a wide range of applications.

We provide unique features to enable in-droplet phenotypic and functional screenings.

  • antibody discovery and optimization
  • cell therapy
  • antibiotics discovery
  • enzyme research
  • and much more...

  • We deploy our experience in custom lab-on-a-chip systems and molecular pharmacology to offer powerful solutions to customers screening needs, helping them succeed in their assays.




    Technology

    GotaHit Lab-on-a-chip Platform

    Within our L2 ambient-controlled facilities,
    we conduct screening services in picoliter droplets
    with unprecedented sensitivity and throughput.

    GotaHit can screen tens of millions of droplets per hour
    down to the single cell analysis.
    Our know-how on the manipulation of miniaturized biological
    reactors spans a range of droplet-based microfluidics operations:

    GotaSoft Screening software

    GotaSoft can analyse in real time phenotypic signatures
    with up to 8 detection channels, enabling screening and sorting rare events
    within millions of droplets.

    The Team

    We are a team of experts in lab-on-a-chip systems and molecular pharmacology
    which strongly believe in the power of droplet microfluidics screening.

    Georges Gaudriault
    CEO

    Georges Gaudriault brings 25 years of experience in Drug Discovery, Drug Delivery and Molecular Pharmacology. After completing his PhD, he initiated an international career in San Diego as a postdoctoral fellow. Upon his return to France, he served as R&D scientist at Institut Curie before turning to the private sector. He served as CSO of MedinCell (2007-2016) and DEINOVE (2016-2022). His vision for the potential of droplet microfluidics in the biotech and pharma industries pushed the creation of Screening & Fluidics.

    Evelio R. Miquet
    CTO

    Evelio R. Miquet brings more than 10 years of experience working in microfluidics and lab-on-a-chip technologies for platform developments. He obtained his BEng degree at InSTEC in Havana and his PhD at LAAS-CNRS/University of Toulouse in 2016. After pursuing postdoctoral work at MPQ/University Paris Diderot, he served as Senior Scientist in optofluidics at HiFiBiO Therapeutics (2018-2021) and as Head of the Lab-on-a-chip Unit within DEINOVE (2021-2023). His passion for advanced technology in addition to his entrepreneurial spirit converged to launch Screening & Fluidics in 2024.

    Benoît Charlot
    Scientific advisor

    Benoît Charlot is a research director at CNRS and head of the BioMicrofluidics and Biophotonics team at the Institut d'Electronique et des Systèmes of the University of Montpellier. For over 15 years he has developped microfluidic and organ-on-chip systems in the fields of neurosciences, oncology and hemophysics. He also has been involved in the development of multiphase microfluidic systems for the generation of droplets and double emulsions.


    Screening & Fluidics is funded by and hosted by

    Contact Screening & Fluidics

    Address : Cap Sigma, ZAC Euromédecine II, 1682 Rue de la Valsière, 34790 Grabels, France

    email: contact@snfluidics.com

    Phone: +33 4 67 52 84 21